Related Experiment Video
Updated: Nov 27, 2025
Author Spotlight: Exploring Strategies for Successful Immune Response Against Tumors
Published on: August 16, 2024
Understanding tumour cell heterogeneity and its implication for immunotherapy in liver cancer using single-cell
Sophia Heinrich1, Amanda J Craig1, Lichun Ma1
1Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, USA.
Abstract:
Over the last decade, precision medicine and immunotherapeutic approaches have become increasingly popular in oncology. Early clinical trials reported promising results, but response rates in phase III clinical trials have been suboptimal. Knowledge gained from subsequent translational studies indicates the importance of targeting the tumour microenvironment to overcome resistance to immunotherapy. In this era of precision medicine, it is crucial to consider inter- as well as intratumoural heterogeneity. Single-cell analysis is a cutting-edge technology that enables us to better define the tumour cell community and to identify potential targets for immunotherapy or combination treatments. This review focuses on single-cell analysis in the context of immunotherapy in liver cancer, including the rationale behind studying hepatocellular carcinoma biology at a single-cell level. Single-cell technologies have the potential to revolutionise our understanding of resistance mechanisms and to guide drug discovery efforts, leading to further advances in personalised medicine.
Insights
Single-cell analysis reveals crucial insights into liver cancer
Area of Science:
- Oncology
- Immunotherapy
- Precision Medicine
Background:
- Precision medicine and immunotherapy show promise in oncology but face suboptimal response rates in late-stage clinical trials.
- Translational studies highlight the importance of the tumor microenvironment in overcoming immunotherapy resistance.
- Inter- and intratumoral heterogeneity are critical factors in precision medicine.
Purpose of the Study:
- To review the application of single-cell analysis in liver cancer immunotherapy.
- To explore the rationale for studying hepatocellular carcinoma at a single-cell level.
- To identify potential targets for novel immunotherapy and combination treatments.
Main Methods:
- Focuses on single-cell analysis technologies.
- Reviews translational studies in oncology.
- Examines hepatocellular carcinoma biology.
Main Results:
- Single-cell analysis enhances the understanding of tumor cell communities.
- It aids in identifying potential therapeutic targets.
- It provides insights into resistance mechanisms.
Conclusions:
- Single-cell analysis is vital for understanding liver cancer heterogeneity and immunotherapy resistance.
- This technology can guide drug discovery for personalized medicine.
- It holds the potential to revolutionize treatment strategies for liver cancer.
